IOVANCE BIOTHERAPEUTICS, INC. Operating Expenses
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Operating Expenses of $110.86 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-05-10
- IOVANCE BIOTHERAPEUTICS, INC. operating expenses for the quarter ending 2023-03-31 was $110.86M, a 20.87% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. operating expenses for the quarter ending 2022-12-31 was $107.04M, a 7.61% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. operating expenses for the quarter ending 2022-09-30 was $100.39M, a 16.41% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. operating expenses for the quarter ending 2022-06-30 was $99.73M, a 22.48% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. operating expenses for fiscal 2022 was $398.88M, a 16.39% increase from fiscal 2021.
- IOVANCE BIOTHERAPEUTICS, INC. operating expenses for fiscal 2021 was $342.70M, a 30.83% increase from fiscal 2020.
- IOVANCE BIOTHERAPEUTICS, INC. operating expenses for fiscal 2020 was $261.94M, a 26.62% increase from fiscal 2019.
- IOVANCE BIOTHERAPEUTICS, INC. operating expenses for fiscal 2019 was $206.87M, a 61.29% increase from fiscal 2018.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 45 month | Operating Expenses 48 month | Operating Expenses 51 month | Operating Expenses 54 month | Operating Expenses 57 month | Operating Expenses 60 month | Operating Expenses 63 month | Operating Expenses 66 month | Operating Expenses 69 month | Operating Expenses 72 month | Operating Expenses 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | $110.86M 10-Q · filed 2023-05-10 | $217.89M derived: sum of 2 quarters · filed 2023-05-10 | $318.29M derived: sum of 3 quarters · filed 2023-05-10 | $418.02M derived: sum of 4 quarters · filed 2023-05-10 | |||||||||||||||
| 2022-12-31 | $107.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $207.43M derived: sum of 2 quarters · filed 2023-02-28 | $307.17M derived: sum of 3 quarters · filed 2023-02-28 | $398.88M 10-K · filed 2023-02-28 | |||||||||||||||
| 2022-09-30 | $100.39M 10-Q · filed 2022-11-03 | $200.13M derived: sum of 2 quarters · filed 2022-11-03 | $291.84M 10-Q · filed 2022-11-03 | $391.31M derived: sum of 4 quarters · filed 2023-05-10 | |||||||||||||||
| 2022-06-30 | $99.73M 10-Q · filed 2022-08-04 | $191.45M 10-Q · filed 2022-08-04 | $290.91M derived: sum of 3 quarters · filed 2023-05-10 | $377.15M derived: sum of 4 quarters · filed 2023-05-10 | |||||||||||||||
| 2022-03-31 | $91.71M 10-Q · filed 2023-05-10 | $191.18M derived: sum of 2 quarters · filed 2023-05-10 | $277.42M derived: sum of 3 quarters · filed 2023-05-10 | $358.85M derived: sum of 4 quarters · filed 2023-05-10 | |||||||||||||||
| 2021-12-31 | $99.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $185.71M derived: sum of 2 quarters · filed 2023-02-28 | $267.13M derived: sum of 3 quarters · filed 2023-02-28 | $342.70M 10-K · filed 2023-02-28 | |||||||||||||||
| 2021-09-30 | $86.24M 10-Q · filed 2022-11-03 | $167.67M derived: sum of 2 quarters · filed 2022-11-03 | $243.24M 10-Q · filed 2022-11-03 | $311.77M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||||||
| 2021-06-30 | $81.43M 10-Q · filed 2022-08-04 | $157.00M 10-Q · filed 2022-08-04 | $225.53M derived: sum of 3 quarters · filed 2023-02-28 | $284.50M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||||||
| 2021-03-31 | $75.57M 10-Q · filed 2022-05-05 | $144.10M derived: sum of 2 quarters · filed 2023-02-28 | $203.07M derived: sum of 3 quarters · filed 2023-02-28 | $266.70M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||||||
| 2020-12-31 | $68.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $127.50M derived: sum of 2 quarters · filed 2023-02-28 | $191.13M derived: sum of 3 quarters · filed 2023-02-28 | $261.94M 10-K · filed 2023-02-28 | |||||||||||||||
| 2020-09-30 | $58.97M 10-Q · filed 2021-11-04 | $122.59M derived: sum of 2 quarters · filed 2021-11-04 | $193.40M 10-Q · filed 2021-11-04 | $258.51M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||||||||
| 2020-06-30 | $63.63M 10-Q · filed 2021-08-05 | $134.44M 10-Q · filed 2021-08-05 | $199.55M derived: sum of 3 quarters · filed 2022-02-24 | $251.16M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||||||||
| 2020-03-31 | $70.81M 10-Q · filed 2021-05-06 | $135.92M derived: sum of 2 quarters · filed 2022-02-24 | $187.53M derived: sum of 3 quarters · filed 2022-02-24 | $237.70M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||||||||
| 2019-12-31 | $65.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $116.72M derived: sum of 2 quarters · filed 2022-02-24 | $166.89M derived: sum of 3 quarters · filed 2022-02-24 | $206.87M 10-K · filed 2022-02-24 | |||||||||||||||
| 2019-09-30 | $51.61M 10-Q · filed 2020-11-05 | $101.78M derived: sum of 2 quarters · filed 2020-11-05 | $141.76M 10-Q · filed 2020-11-05 | $176.71M derived: sum of 4 quarters · filed 2021-02-25 | |||||||||||||||
| 2019-06-30 | $50.16M 10-Q · filed 2020-08-06 | $90.15M 10-Q · filed 2020-08-06 | $125.09M derived: sum of 3 quarters · filed 2021-02-25 | $160.15M derived: sum of 4 quarters · filed 2021-02-25 | |||||||||||||||
| 2019-03-31 | $39.99M 10-Q · filed 2020-05-05 | $74.93M derived: sum of 2 quarters · filed 2021-02-25 | $109.99M derived: sum of 3 quarters · filed 2021-02-25 | $141.37M derived: sum of 4 quarters · filed 2021-02-25 | |||||||||||||||
| 2018-12-31 | $34.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $70.00M derived: sum of 2 quarters · filed 2021-02-25 | $101.38M derived: sum of 3 quarters · filed 2021-02-25 | $128.26M 10-K · filed 2021-02-25 | |||||||||||||||
| 2018-09-30 | $35.06M 10-Q · filed 2019-11-04 | $66.44M derived: sum of 2 quarters · filed 2019-11-04 | $93.31M 10-Q · filed 2019-11-04 | $119.39M derived: sum of 4 quarters · filed 2020-02-25 | |||||||||||||||
| 2018-06-30 | $31.38M 10-Q · filed 2019-08-01 | $58.26M 10-Q · filed 2019-08-01 | $84.33M derived: sum of 3 quarters · filed 2020-02-25 | $106.67M derived: sum of 4 quarters · filed 2020-02-25 | |||||||||||||||
| 2018-03-31 | $26.88M 10-Q · filed 2019-05-07 | $52.95M derived: sum of 2 quarters · filed 2020-02-25 | $75.29M derived: sum of 3 quarters · filed 2020-02-25 | $98.87M derived: sum of 4 quarters · filed 2020-02-25 | |||||||||||||||
| 2017-12-31 | $26.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $48.41M derived: sum of 2 quarters · filed 2020-02-25 | $72.00M derived: sum of 3 quarters · filed 2020-02-25 | $92.88M 10-K · filed 2020-02-25 | |||||||||||||||
| 2017-09-30 | $22.34M 10-Q · filed 2018-11-06 | $45.92M derived: sum of 2 quarters · filed 2018-11-06 | $66.81M 10-Q · filed 2018-11-06 | $82.73M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||||||
| 2017-06-30 | $23.58M 10-Q · filed 2018-08-07 | $44.46M 10-Q · filed 2018-08-07 | $60.38M derived: sum of 3 quarters · filed 2019-02-28 | $79.36M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||||||
| 2017-03-31 | $20.88M 10-Q · filed 2018-05-10 | $36.80M derived: sum of 2 quarters · filed 2019-02-28 | $55.78M derived: sum of 3 quarters · filed 2019-02-28 | $67.51M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||||||
| 2016-12-31 | $15.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $34.90M derived: sum of 2 quarters · filed 2019-02-28 | $46.63M derived: sum of 3 quarters · filed 2019-02-28 | $53.64M 10-K · filed 2019-02-28 | |||||||||||||||
| 2016-09-30 | $18.98M 10-Q · filed 2017-11-02 | $30.71M derived: sum of 2 quarters · filed 2017-11-02 | $37.72M 10-Q · filed 2017-11-02 | $46.20M derived: sum of 4 quarters · filed 2018-03-12 | |||||||||||||||
| 2016-06-30 | $11.73M 10-Q · filed 2017-08-03 | $18.74M 10-Q · filed 2017-08-03 | $27.22M derived: sum of 3 quarters · filed 2018-03-12 | $34.86M derived: sum of 4 quarters · filed 2018-03-12 | |||||||||||||||
| 2016-03-31 | $7.01M 10-Q · filed 2017-05-03 | $15.49M derived: sum of 2 quarters · filed 2018-03-12 | $23.13M derived: sum of 3 quarters · filed 2018-03-12 | $29.57M derived: sum of 4 quarters · filed 2018-03-12 | |||||||||||||||
| 2015-12-31 | $8.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $16.12M derived: sum of 2 quarters · filed 2018-03-12 | $22.56M derived: sum of 3 quarters · filed 2018-03-12 | $27.86M 10-K · filed 2018-03-12 | |||||||||||||||
| 2015-09-30 | $7.64M 10-Q · filed 2016-11-04 | $14.08M derived: sum of 2 quarters · filed 2016-11-04 | $19.38M 10-Q · filed 2016-11-04 | $19.41M 10-Q · filed 2015-11-06 | $24.25M derived: sum of 4 quarters · filed 2017-03-09 | ||||||||||||||
| 2015-06-30 | $6.44M 10-Q · filed 2016-08-09 | $6.44M 10-Q · filed 2015-08-10 | $11.74M 10-Q · filed 2016-08-09 | $11.74M 10-Q · filed 2015-08-10 | $16.61M derived: sum of 3 quarters · filed 2017-03-09 | $19.41M derived: sum of 4 quarters · filed 2017-03-09 | |||||||||||||
| 2015-03-31 | $5.30M 10-Q · filed 2016-05-09 | $5.30M 10-Q · filed 2015-05-11 | $10.17M derived: sum of 2 quarters · filed 2017-03-09 | $12.97M derived: sum of 3 quarters · filed 2017-03-09 | $15.08M derived: sum of 4 quarters · filed 2017-03-09 | ||||||||||||||
| 2014-12-31 | $4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $7.67M derived: sum of 2 quarters · filed 2017-03-09 | $9.78M derived: sum of 3 quarters · filed 2017-03-09 | $12.04M 10-K · filed 2017-03-09 | $12.04M 10-K · filed 2015-03-16 | ||||||||||||||
| 2014-09-30 | $2.80M 10-Q · filed 2015-11-06 | $2.80M 10-Q · filed 2014-11-13 | $4.91M derived: sum of 2 quarters · filed 2015-11-06 | $7.17M 10-Q · filed 2015-11-06 | $7.17M 10-Q · filed 2014-11-13 | $18.67M derived: sum of 4 quarters · filed 2016-03-11 | |||||||||||||
| 2014-06-30 | $2.11M 10-Q · filed 2015-08-10 | $4.37M 10-Q · filed 2015-08-10 | $15.87M derived: sum of 3 quarters · filed 2016-03-11 | $25.28M derived: sum of 4 quarters · filed 2016-03-11 | |||||||||||||||
| 2014-03-31 | $2.26M 10-Q · filed 2015-05-11 | $13.76M derived: sum of 2 quarters · filed 2016-03-11 | $23.17M derived: sum of 3 quarters · filed 2016-03-11 | $24.20M derived: sum of 4 quarters · filed 2016-03-11 | $55.14M 10-Q · filed 2014-05-14 | ||||||||||||||
| 2013-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $20.91M derived: sum of 2 quarters · filed 2016-03-11 | $21.94M derived: sum of 3 quarters · filed 2016-03-11 | $22.64M 10-K · filed 2016-03-11 | $22.64M 10-K · filed 2014-03-28 | $52.88M 10-K · filed 2014-03-28 | |||||||||||||
| 2013-09-30 | $9.41M 10-Q · filed 2014-11-13 | $10.44M derived: sum of 2 quarters · filed 2014-11-13 | $11.14M 10-Q · filed 2014-11-13 | $12.87M derived: sum of 4 quarters · filed 2014-11-13 | $41.38M 10-Q · filed 2013-11-14 | ||||||||||||||
| 2013-06-30 | $1.03M 10-Q · filed 2014-08-08 | $1.73M 10-Q · filed 2014-08-08 | $3.46M derived: sum of 3 quarters · filed 2014-08-08 | $5.08M derived: sum of 4 quarters · filed 2014-08-08 | $31.98M 10-Q · filed 2013-10-23 | ||||||||||||||
| 2013-03-31 | $704.91K 10-Q · filed 2014-05-14 | $2.43M derived: sum of 2 quarters · filed 2014-05-14 | $4.06M derived: sum of 3 quarters · filed 2014-05-14 | $5.70M derived: sum of 4 quarters · filed 2014-05-14 | $30.95M 10-Q · filed 2013-10-23 | ||||||||||||||
| 2012-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $3.35M derived: sum of 2 quarters · filed 2014-03-28 | $5.00M derived: sum of 3 quarters · filed 2014-03-28 | $8.13M 10-K · filed 2014-03-28 | $30.24M 10-K · filed 2013-09-23 | ||||||||||||||
| 2012-09-30 | $1.63M 10-Q · filed 2013-11-14 | $3.27M derived: sum of 2 quarters · filed 2013-11-14 | $6.41M 10-Q · filed 2013-11-14 | $10.59M derived: sum of 4 quarters · filed 2013-11-14 | $28.52M 10-Q · filed 2013-01-25 | ||||||||||||||
| 2012-06-30 | $1.65M 10-Q · filed 2013-10-23 | $4.78M 10-Q · filed 2013-10-23 | $8.97M derived: sum of 3 quarters · filed 2013-10-23 | $14.78M derived: sum of 4 quarters · filed 2013-10-23 | $26.89M 10-Q/A · filed 2012-09-10 | ||||||||||||||
| 2012-03-31 | $3.14M 10-Q · filed 2013-10-23 | $7.32M derived: sum of 2 quarters · filed 2013-10-23 | $13.14M derived: sum of 3 quarters · filed 2013-10-23 | $23.70M derived: sum of 4 quarters · filed 2013-10-23 | $25.24M 10-Q · filed 2012-05-15 | ||||||||||||||
| 2011-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | $10.00M derived: sum of 2 quarters · filed 2013-09-23 | $20.56M derived: sum of 3 quarters · filed 2013-09-23 | $21.22M 10-K · filed 2013-09-23 | $22.11M 10-K · filed 2012-03-30 | ||||||||||||||
| 2011-09-30 | $5.81M 10-Q · filed 2013-01-25 | $16.38M derived: sum of 2 quarters · filed 2013-01-25 | $17.03M 10-Q · filed 2013-01-25 | $17.53M derived: sum of 4 quarters · filed 2013-01-25 | $17.92M 10-Q · filed 2011-11-21 | ||||||||||||||
| 2011-06-30 | $10.56M 10-Q/A · filed 2012-09-10 | $11.22M 10-Q/A · filed 2012-09-10 | $11.72M derived: sum of 3 quarters · filed 2012-09-10 | $11.88M derived: sum of 4 quarters · filed 2012-09-10 | $12.11M 10-Q/A · filed 2011-09-01 | ||||||||||||||
| 2011-03-31 | $658.25K 10-Q · filed 2012-05-15 | $1.15M derived: sum of 2 quarters · filed 2012-05-15 | $1.32M derived: sum of 3 quarters · filed 2012-05-15 | $1.41M derived: sum of 4 quarters · filed 2012-05-15 | |||||||||||||||
| 2010-12-31 | $496.08K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $663.10K derived: sum of 2 quarters · filed 2012-03-30 | $747.73K derived: sum of 3 quarters · filed 2012-03-30 | $815.41K 10-K · filed 2012-03-30 | |||||||||||||||
| 2010-09-30 | $167.03K 10-Q · filed 2011-11-21 | $251.66K derived: sum of 2 quarters · filed 2011-11-21 | $319.34K 10-Q · filed 2011-11-21 | ||||||||||||||||
| 2010-06-30 | $84.63K 10-Q/A · filed 2011-09-01 | $152.31K 10-Q/A · filed 2011-09-01 | |||||||||||||||||
| 2009-12-31 | $15.77K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |